Denmark· DK-28106364519
Libmeldy
A atidarsagene autotemcel product containing atidarsagene autotemcel, registered in Denmark by Orchard Therapeutics BV. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Atidarsagene autotemcel is registered in 9 of 19 countries.
Countries holding a registration under ATC A16AB21 (atidarsagene autotemcel), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Atidarsagene autotemcel · ATC A16AB21
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Atidarsagene autotemcel
- Manufacturer
- Orchard Therapeutics BV
- Country
- Denmark (DK)
- ATC code
- A16AB21
- ATC class
- Atidarsagene autotemcel
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106364519
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A16AB21
Atidarsagene autotemcel, as other registers publish it.
- United StatesLENMELDYOrchard Therapeutics (Europe) Ltd
- United StatesLENMELDYOrchard Therapeutics (Europe) Ltd
- IcelandLibmeldyOrchard Therapeutics (Netherlands) B.V.
- PolandLibmeldyOrchard Therapeutics (Netherlands) BV
- FinlandLibmeldyOrchard Therapeutics (Netherlands) BV
- CzechiaLIBMELDYOrchard Therapeutics (Netherlands) B.V., Leiden
- BelgiumLibmeldy 2 10*6 cells/ml - 10 10*6 cells/mlOrchard Therapeutics (Netherlands)
- IrelandLibmeldy 2-10 x 106 cells/mL dispersion for infusionOrchard Therapeutics (Netherlands) B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/487ab56c-bb9c-4681-ab88-8601b6537b04 GET /v1/drugs/487ab56c-bb9c-4681-ab88-8601b6537b04?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "infusionsvæske, dispersion",
"source": "dkma",
"strength": "autologe CD34+celler",
"auth_role": "MOD",
"dk_drugid": "28106364519",
"substance": "Atidarsagene autotemcel",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "44182"
}See everything about atidarsagene autotemcel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.